This site is intended for healthcare professionals only
LoginRegister
Senores PharmaSenores Pharma gets Philippine FDA approval for basket of 10 products
Biocon Secures Rs 4,150 Cr Through QIP to Buy Out Viatris Stake in Biologics ArmBiocon Pharma gains tentative USFDA nod for Parkinson's disease capsules
PG Pharmacy Admissions 2025: Kerala Opens Mop-Up Counselling for M.Pharm, Fresh Options MandatoryPG Pharmacy Admissions 2025: Kerala Opens Mop-Up Counselling for M.Pharm, Fresh Options Mandatory
ITAT Delhi Grants Relief to Pharmacy Owner, Deletes Rs 19.68 Lakh Addition on Demonetisation-Era SalesHaryana Pharmacy Council to Deregister Pharmacists Over Illegal Sale of Psychotropic Drugs, MTP Kits
Abuse of the Process of Law: Delhi HC Upholds Dismissal of Complaint Against Hospital, Doctor Accused of Medical NegligenceSemaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to...
Ipca Pharma incorporates new wholly owned arm in Federal Republic of GermanyIpca Labs receives 3 USFDA observations for Tarapur facility
Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone LymphomaBristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma
CDSCO Panel Flags Gaps in Serum Institutes rBCG Vaccine Data, Calls for Stronger TrialIndia renew Engagement Strategy with CEPI for cooperation on vaccine, allied technology RnD
Chhattisgarh clears over Rs 46 crore for new drug-testing lab and FDA buildingChhattisgarh clears over Rs 46 crore for new drug-testing lab and FDA building
Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide DealLupin secures tentative USFDA nod for multiple sclerosis drug Siponimod
Govt Panel Approves Inclusion of Emergency Contraceptive Levonorgestrel Under Schedule KGovt Panel Approves Inclusion of Emergency Contraceptive Levonorgestrel Under Schedule K
CDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III StudyCDSCO Panel Denies Trial Waiver for Atropine, Asks Sun Pharma to Conduct Phase III Study
X